{"id":730434,"date":"2025-02-06T10:02:02","date_gmt":"2025-02-06T10:02:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=730434"},"modified":"2025-02-06T10:02:02","modified_gmt":"2025-02-06T10:02:02","slug":"myopia-progression-market-expected-to-rise-2034-johnson-johnson-vision-care-inc-beijing-airdoc-technology-co-ltd-essilor-international-menicon-co-ltd-sightglass-vision-inc-indizen-opti","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/myopia-progression-market-expected-to-rise-2034-johnson-johnson-vision-care-inc-beijing-airdoc-technology-co-ltd-essilor-international-menicon-co-ltd-sightglass-vision-inc-indizen-opti_730434.html","title":{"rendered":"Myopia Progression Market Expected to rise, 2034 | Johnson &#038; Johnson Vision Care, Inc, Beijing Airdoc Technology Co., Ltd, Essilor International, Menicon Co., Ltd., SightGlass Vision Inc, Indizen Opti"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/upload\/2025\/02\/1738685829.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Myopia Progression Market Expected to rise, 2034 | Johnson &amp; Johnson Vision Care, Inc, Beijing Airdoc Technology Co., Ltd, Essilor International, Menicon Co., Ltd., SightGlass Vision Inc, Indizen Opti\" src=\"https:\/\/www.abnewswire.com\/upload\/2025\/02\/1738685829.jpg\" alt=\"Myopia Progression Market Expected to rise, 2034 | Johnson &amp; Johnson Vision Care, Inc, Beijing Airdoc Technology Co., Ltd, Essilor International, Menicon Co., Ltd., SightGlass Vision Inc, Indizen Opti\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Myopia Progression Market 2034<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Myopia Progression market growth is driven by factors like increase in the prevalence of Myopia Progression, investments in research and development, entry of emerging therapies during the study period 2020-2034.<\/div>\n<p style=\"text-align: justify;\">The <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Myopia Progression market report<\/a> also offers comprehensive insights into the Myopia Progression market size, share, Myopia Progression epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Myopia Progression market size growth forward.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key highlights from the Myopia Progression Market Insights Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Several key pharmaceutical companies, including Johnson &amp; Johnson Vision Care, Inc, Beijing Airdoc Technology Co., Ltd, Essilor International, Menicon Co., Ltd., SightGlass Vision Inc, Indizen Optical Technologies, S.L.U., Bausch &amp; Lomb Incorporated, Coopervision Inc, and others, are developing novel products to improve the Myopia Progression treatment outlook.<\/p>\n<\/li>\n<li>\n<p>In December 2024, Oupushifang Pharmaceutical Technology Co., Ltd. conducted a study to evaluate the effectiveness of 0.01% and 0.02% atropine sulfate eye drops in slowing myopia progression in children and adolescents over a 96-week period, in comparison to a placebo. The study also aimed to assess the safety of these eye drops for delaying myopia progression in this age group.<\/p>\n<\/li>\n<li>\n<p>As per DelveInsight analysis, the Myopia Progression market is anticipated to witness growth at a considerable CAGR<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Strategise your business goals by understanding market dynamics @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-progression-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Myopia Progression Market Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Myopia Progression Overview <\/strong><\/p>\n<p style=\"text-align: justify;\">The Myopia Progression Treatment Market refers to the healthcare sector focused on addressing the growing global prevalence of myopia, or nearsightedness. Myopia is a vision condition where distant objects appear blurry, and its incidence has been increasing, particularly among children and young adults. As a result, there is rising demand for effective treatments to slow or stop the progression of myopia. The market includes a variety of treatment options, such as orthokeratology (Ortho-K), atropine eye drops, multifocal contact lenses, and other pharmaceutical solutions. Diagnosing myopia progression is an essential step in assessing how the condition is advancing. This diagnostic process involves a thorough evaluation of the eye&rsquo;s refractive error to accurately measure the degree of myopia. Ophthalmologists or optometrists use several methods for diagnosis, including visual acuity tests, refraction measurements, and axial length assessments of the eye. This section of the report provides an in-depth look at the diagnostic tests for myopia progression.<\/p>\n<p style=\"text-align: justify;\"><strong>Do you know the treatment paradigms for different countries? Download our <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Myopia Progression Market Sample Report<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Myopia Progression Epidemiology Segmentation <\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s Myopia Progression market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Myopia Progression historical patient pools and forecasted Myopia Progression patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Myopia Progression Market report proffers epidemiological analysis for the study period 2020-34 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Myopia Progression Prevalence<\/p>\n<\/li>\n<li>\n<p>Age-Specific Myopia Progression Prevalence<\/p>\n<\/li>\n<li>\n<p>Gender-Specific Myopia Progression Prevalence<\/p>\n<\/li>\n<li>\n<p>Diagnosed and Treatable Cases of Myopia Progression<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Visit for more @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-progression-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Myopia Progression Epidemiological Insights<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Myopia Progression Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">The outlook for the Myopia Progression Market looks promising, driven by ongoing advancements in research and technology within the field of ophthalmology. Myopia, or nearsightedness, affects a significant portion of the global population, particularly among younger individuals. As the prevalence of myopia continues to rise, there is an increasing demand for effective and accessible treatment options to manage its progression. The market is experiencing a surge in the development of new pharmaceuticals, optical devices, and therapies designed to slow myopia progression and enhance visual outcomes.<\/p>\n<p style=\"text-align: justify;\">This section provides a comprehensive analysis of market trends for each available drug and late-stage pipeline therapy, evaluating factors such as the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rates, market demand, patient population, expected launch dates, competition, brand value, and the overall market impact, as seen by key opinion leaders. The Myopia Progression market outlook is presented with relevant tables and charts, offering a clear and detailed view of the market at a glance.<\/p>\n<p style=\"text-align: justify;\"><strong>Myopia Progression Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Johnson &amp; Johnson Vision Care, Inc, Beijing Airdoc Technology Co., Ltd, Essilor International, Menicon Co., Ltd., SightGlass Vision Inc, Indizen Optical Technologies, S.L.U., Bausch &amp; Lomb Incorporated, Coopervision Inc, and others<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>For more information, visit <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=abnewswire&amp;utm_medium=market&amp;utm_campaign=kpr\">Myopia Progression Market Analysis, Patient Pool, and Emerging Therapies<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Myopia Progression Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>11 Years Forecast<\/p>\n<\/li>\n<li>\n<p>7MM Coverage<\/p>\n<\/li>\n<li>\n<p>Descriptive overview of Myopia Progression, causes, signs and symptoms, diagnosis, treatment<\/p>\n<\/li>\n<li>\n<p>Comprehensive insight into Myopia Progression epidemiology in the 7MM<\/p>\n<\/li>\n<li>\n<p>Myopia Progression marketed and emerging therapies<\/p>\n<\/li>\n<li>\n<p>Myopia Progression companies<\/p>\n<\/li>\n<li>\n<p>Myopia Progression market drivers and barriers<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1 Myopia Progression Market Key Comprehensive Insights<\/p>\n<p style=\"text-align: justify;\">2 Myopia Progression Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">3 Competitive Intelligence Analysis for Myopia Progression<\/p>\n<p style=\"text-align: justify;\">4 Myopia Progression Market Analysis Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5 Executive Summary of Myopia Progression<\/p>\n<p style=\"text-align: justify;\">6 Myopia Progression Epidemiology and Market Methodology<\/p>\n<p style=\"text-align: justify;\">7 Myopia Progression Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8 Myopia Progression Patient Journey<\/p>\n<p style=\"text-align: justify;\">9 Myopia Progression Treatment Algorithm, Myopia Progression Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10 Key Endpoints in Myopia Progression Clinical Trials<\/p>\n<p style=\"text-align: justify;\">11 Myopia Progression Marketed Therapies<\/p>\n<p style=\"text-align: justify;\">12 Myopia Progression Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">13 Myopia Progression: 7 Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14 Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15 Access and Reimbursement Overview of Myopia Progression<\/p>\n<p style=\"text-align: justify;\">16 Myopia Progression Market Key Opinion Leaders Reviews<\/p>\n<p style=\"text-align: justify;\">18 Myopia Progression Market Drivers<\/p>\n<p style=\"text-align: justify;\">19 Myopia Progression Market Barriers<\/p>\n<p style=\"text-align: justify;\">20 SWOT Analysis<\/p>\n<p style=\"text-align: justify;\">21 Disclaimer<\/p>\n<p style=\"text-align: justify;\">22 DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">23 About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Myopia Progression Epidemiology 2034<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8220;Myopia Progression &#8211; Epidemiology Forecast to 2034&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Myopia Progression epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>Myopia Progression Pipeline 2024<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8220;Myopia Progression Pipeline Insights, 2024&#8221; report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Myopia Progression market. A detailed picture of the Myopia Progression pipeline landscape is provided, which includes the disease overview and Myopia Progression treatment guidelines.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=myopia-progression-market-expected-to-rise-2034-johnson-johnson-vision-care-inc-beijing-airdoc-technology-co-ltd-essilor-international-menicon-co-ltd-sightglass-vision-inc-indizen-opti\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +14699457679<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=myopia-progression-market-expected-to-rise-2034-johnson-johnson-vision-care-inc-beijing-airdoc-technology-co-ltd-essilor-international-menicon-co-ltd-sightglass-vision-inc-indizen-opti\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Myopia Progression Market 2034 The Myopia Progression market growth is driven by factors like increase in the prevalence of Myopia Progression, investments in research and development, entry of emerging therapies during the study period 2020-2034. The Myopia Progression market report &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/myopia-progression-market-expected-to-rise-2034-johnson-johnson-vision-care-inc-beijing-airdoc-technology-co-ltd-essilor-international-menicon-co-ltd-sightglass-vision-inc-indizen-opti_730434.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-730434","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/730434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=730434"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/730434\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=730434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=730434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=730434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}